Fuso Pharmaceutical Industries (TSE:4538) Cyclically Adjusted Revenue per Share: 円6,352.68 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4538 Fuso Pharmaceutical Industries Ltd TSE:4538
60 GF Score
Price 円2,191.00
GF Value 円2,579.34
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fuso Pharmaceutical Industries Cyclically Adjusted Revenue per Share?

Fuso Pharmaceutical Industries TSE:4538 +1.20% 60 Cyclically Adjusted Revenue per Share is 円6,352.68 as of Mar. 2026. GuruFocus rates TSE:4538 with a GF Score™ of 60/100 and a GF Value™ of 円2,579.34 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Fuso Pharmaceutical Industries's adjusted revenue per share for the three months ended in Mar. 2026 was 円1,644.455. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円6,352.68 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Fuso Pharmaceutical Industries's average Cyclically Adjusted Revenue Growth Rate was 3.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Fuso Pharmaceutical Industries was 4.30% per year. The lowest was 0.20% per year. And the median was 1.20% per year.

As of today (2026-08-11), Fuso Pharmaceutical Industries's current stock price is 円2191.00. Fuso Pharmaceutical Industries's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円6,352.68. Fuso Pharmaceutical Industries's Cyclically Adjusted PS Ratio of today is 0.34.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fuso Pharmaceutical Industries was 0.57. The lowest was 0.32. And the median was 0.40.


Fuso Pharmaceutical Industries  (TSE:4538) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Fuso Pharmaceutical Industries's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2191.00/6352.68
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fuso Pharmaceutical Industries was 0.57. The lowest was 0.32. And the median was 0.40.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Fuso Pharmaceutical Industries Cyclically Adjusted Revenue per Share Related Terms


Fuso Pharmaceutical Industries Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Fuso Pharmaceutical Industries's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuso Pharmaceutical Industries Cyclically Adjusted Revenue per Share Chart

Fuso Pharmaceutical Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,483.25 5,655.51 5,845.37 0.00 6,352.68

Fuso Pharmaceutical Industries Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 6,193.48 6,248.76 6,358.18 6,352.68

TSE:4538 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fuso Pharmaceutical Industries's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuso Pharmaceutical Industries Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuso Pharmaceutical Industries's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fuso Pharmaceutical Industries's Cyclically Adjusted PS Ratio falls into.


TSE:4538
60GF Score
Fuso Pharmaceutical Industries Ltd TSE:4538
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuso Pharmaceutical Industries Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fuso Pharmaceutical Industries's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1644.455/112.7000*112.7000
=1,644.455

Current CPI (Mar. 2026) = 112.7000.

Fuso Pharmaceutical Industries Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 1,152.792 97.900 1,327.065
201606 1,310.516 98.100 1,505.557
201609 1,312.286 98.000 1,509.129
201612 1,380.515 98.400 1,581.139
201703 1,183.333 98.100 1,359.446
201706 1,288.225 98.500 1,473.939
201709 1,300.293 98.800 1,483.229
201712 1,409.168 99.400 1,597.719
201803 1,188.802 99.200 1,350.585
201806 1,293.950 99.200 1,470.042
201809 1,320.688 99.900 1,489.905
201812 1,443.609 99.700 1,631.843
201903 1,190.861 99.700 1,346.139
201906 1,338.803 99.800 1,511.855
201909 1,358.820 100.100 1,529.860
201912 1,430.720 100.500 1,604.399
202003 1,216.296 100.300 1,366.666
202006 1,416.686 99.900 1,598.203
202009 1,424.664 99.900 1,607.204
202012 1,513.791 99.300 1,718.069
202103 1,258.234 99.900 1,419.449
202106 1,436.275 99.500 1,626.816
202109 1,409.666 100.100 1,587.106
202112 1,516.585 100.100 1,707.484
202203 1,294.701 101.100 1,443.252
202206 1,409.987 101.800 1,560.958
202209 1,482.444 103.100 1,620.480
202212 1,578.659 104.100 1,709.077
202303 1,344.887 104.400 1,451.808
202306 1,540.137 105.200 1,649.938
202309 1,603.341 106.200 1,701.474
202312 1,815.033 106.800 1,915.302
202403 1,471.738 107.200 1,547.247
202406 1,713.181 108.200 1,784.432
202409 1,769.519 108.900 1,831.265
202503 0.000 111.100 0.000
202506 1,816.829 111.700 1,833.094
202509 1,841.668 112.000 1,853.178
202512 1,995.081 113.000 1,989.784
202603 1,644.455 112.700 1,644.455

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円6,352.68 mean?
Fuso Pharmaceutical Industries (TSE:4538) has a Cyclically Adjusted Revenue per Share of 円6,352.68 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Fuso Pharmaceutical Industries and its competitors.
Is Fuso Pharmaceutical Industries' Cyclically Adjusted Revenue per Share too high?
Fuso Pharmaceutical Industries' current Cyclically Adjusted Revenue per Share is 円6,352.68. Overall, Fuso Pharmaceutical Industries has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fuso Pharmaceutical Industries' Cyclically Adjusted Revenue per Share compare to ZTS?
Fuso Pharmaceutical Industries' Cyclically Adjusted Revenue per Share of 円6,352.68 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Fuso Pharmaceutical Industries and its competitors. Fuso Pharmaceutical Industries's current Cyclically Adjusted Revenue per Share is 円6,352.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuso Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Fuso Pharmaceutical Industries (TSE:4538) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,579.34, compared to a current price of 円2,191.00 — trading 15.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円6,352.68. Fuso Pharmaceutical Industries' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Fuso Pharmaceutical Industries (TSE:4538), the current Cyclically Adjusted Revenue per Share is 円6,352.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuso Pharmaceutical Industries (TSE:4538) Overvalued in 2026?

Based on GuruFocus' analysis, Fuso Pharmaceutical Industries stock appears to be undervalued. The current stock price of 円2,191.00 is trading 15.1% below its estimated GF Value™ of 円2,579.34. GuruFocus considers Fuso Pharmaceutical Industries to be Modestly Undervalued.

Key valuation signals for TSE:4538:

  • Cyclically Adjusted Revenue per Share: 円6,352.68
  • GF Value™: 円2,579.34 vs. price of 円2,191.00 (15.1% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the TSE:4538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fuso Pharmaceutical Industries Business Description

Address No. 10, No. 7-chome Doshomachi, Chuo-ku, OsaKa, JPN, 541-0045
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid. Company also includes real estate segment.
60GF Score

Get the complete analysis for TSE:4538

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,191.00
Price
円2,579.34
GF Value